Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Syros Pharmaceuticals, Inc. | 4,242,051 | reported | 17 Jul 2019 | tx 3−63,000 |
| AGIOS PHARMACEUTICALS, INC. | 3,474,664 | reported | 23 Jun 2014 | tx 1−386,074 |
| Ruthigen, Inc. | 3,436,456 | reported | 03 Apr 2018 | tx 3+3,450,000 |
| PHASERX, INC. | 9,385 | reported | 23 May 2016 | tx 4+1,009,385−680,059 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jul 2019 | SALE | Syros Pharmaceuticals, Inc. | 2,700 | 8.27 USD | |
| 16 Jul 2019 | SALE | Syros Pharmaceuticals, Inc. | 25,779 | 7.81 USD | |
| 17 Jul 2019 | SALE | Syros Pharmaceuticals, Inc. | 34,521 | 7.70 USD | |
| 03 Apr 2018 | PURCHASE | Ruthigen, Inc. | 1,150,000 | — | first after silence |
| 03 Apr 2018 | PURCHASE | Ruthigen, Inc. | 1,150,000 | — | deriv |
| 03 Apr 2018 | PURCHASE | Ruthigen, Inc. | 1,150,000 | — | deriv |
| 23 May 2016 | SALE | PHASERX, INC. | 484,903 | 0.01 USD | |
| 23 May 2016 | PURCHASE | PHASERX, INC. | 1,000,000 | 5.00 USD | |
| 23 May 2016 | SALE | PHASERX, INC. | 195,156 | 0.01 USD | |
| 23 May 2016 | GRANT_AWARD | PHASERX, INC. | 9,385 | 0.00 USD | deriv |
| 23 Jun 2014 | OTHER | AGIOS PHARMACEUTICALS, INC. | 386,074 | — |
1 purchase reported after at least 12 months of silence — most recent on 03 Apr 2018.